Kathleen M. Lee, MBA, Ph.D
Vice President, CMC (Chemistry, Manufacturing and Controls)
Kathleen Lee joined the company in 2012. She has over 20 years of experience in the development and manufacture of parenteral and solid dosage forms from preclinical through commercialization. She previously held positions at InteKrin Therapeutics, Scios (J&J), Oread and Syntex (Roche), with diverse responsibility in CMC areas of formulation development, analytical and process chemistry, manufacturing, project management and outsourcing management for both small and large molecules. She is a member of the American Association of Pharmaceutical Scientists (aaps). She holds a B.S. in chemistry and M.B.A. in finance from the University of California, Berkeley, and an M.S. in mathematics and M.S. and Ph.D. in pharmaceutics from the University of Michigan, Ann Arbor.